Factors related to the experience of menopausal symptoms in women prescribed tamoxifen

Abstract Introduction: Menopausal symptoms are frequent and severe in breast cancer survivors taking tamoxifen; however, treatment options are limited for these patients as hormonal replacement therapy is contraindicated. This study aimed to explore the experience and attribution of menopausal symptoms and identify factors related to the experience of menopausal symptoms in women taking tamoxifen. Methods: Women who had been prescribed tamoxifen for a diagnosis of primary breast cancer were recruited from oncology clinics across England and from online advertisements. Seven hundred and forty women completed questionnaires assessing illness perceptions, social support, mood and symptom duration/severity. Results: Eighty-four percent of women had experienced hot flushes and 80% experienced night sweats; of these, 60% experienced severe symptoms. Symptoms persisted throughout 5 years of treatment and were mainly attributed to tamoxifen. Logistic regressions showed that depressive symptoms, previous chemotherapy and being employed were associated with increased odds of hot flush or night sweat prevalence. Symptom severity was associated with depression, being employed and attributing symptoms to tamoxifen. Discussion: These findings have clinical implications in terms of targeting women who are more at risk and offering non-hormonal treatment options, such as cognitive behavioural therapy, to help women to develop self-management strategies for coping with menopausal symptoms.

[1]  G. Jack,et al.  Menopause in the workplace: What employers should be doing. , 2016, Maturitas.

[2]  E. Mullins,et al.  Annual Report of the Chief Medical Officer, 2014 The Health of the 51%: Women , 2015 .

[3]  M. Hunter,et al.  Helping Patients to Help Themselves after Breast Cancer Treatment. , 2015, Clinical oncology (Royal College of Radiologists (Great Britain)).

[4]  K. Newton,et al.  Nonhormonal management of menopause-associated vasomotor symptoms: 2015 position statement of The North American Menopause Society , 2015, Menopause.

[5]  J. Marôco,et al.  Hot Flushes and Night Sweats in Midlife: Why do Some Women Have Them and Others do Not? , 2015 .

[6]  S. Davis,et al.  Menopausal symptoms in breast cancer survivors nearly 6 years after diagnosis , 2014, Menopause.

[7]  M. Gass,et al.  The North American Menopause Society recommendations for clinical care of midlife women. , 2014, Menopause.

[8]  Keith J. Petrie,et al.  Contributors to nonadherence and nonpersistence with endocrine therapy in breast cancer survivors recruited from an online research registry , 2014, Breast Cancer Research and Treatment.

[9]  M. Aloia,et al.  Cognitive behavioral therapy for insomnia outcomes in women after primary breast cancer treatment: a randomized, controlled trial. , 2014, Oncology nursing forum.

[10]  M. Hickey,et al.  Nature and severity of menopausal symptoms and their impact on quality of life and sexual function in cancer survivors compared with women without a cancer history , 2014, Menopause.

[11]  D. Fenlon,et al.  Is it me or is it hot in here? A plea for more research into hot flushes. , 2013, Clinical oncology (Royal College of Radiologists (Great Britain)).

[12]  Amanda Griffiths,et al.  Menopause and work: an electronic survey of employees' attitudes in the UK. , 2013, Maturitas.

[13]  J. Chilcot,et al.  Testing a cognitive model of menopausal hot flushes and night sweats. , 2013, Journal of psychosomatic research.

[14]  Ming-Feng Hou,et al.  Long-term effects of continuing adjuvant tamoxifen to 10 years versus stopping at 5 years after diagnosis of oestrogen receptor-positive breast cancer: ATLAS, a randomised trial , 2013, The Lancet.

[15]  S. L'espérance,et al.  Pharmacological and non-hormonal treatment of hot flashes in breast cancer survivors: CEPO review and recommendations , 2013, Supportive Care in Cancer.

[16]  X. Castells,et al.  Can the Gail model increase the predictive value of a positive mammogram in a European population screening setting? Results from a Spanish cohort. , 2013, Breast.

[17]  N. Aaronson,et al.  Efficacy of cognitive behavioral therapy and physical exercise in alleviating treatment-induced menopausal symptoms in patients with breast cancer: results of a randomized, controlled, multicenter trial. , 2012, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[18]  E. Grunfeld,et al.  Cognitive behavioural treatment for women who have menopausal symptoms after breast cancer treatment (MENOS 1): a randomised controlled trial , 2012, The Lancet. Oncology.

[19]  I. Jacobs,et al.  Prevalence, frequency and problem rating of hot flushes persist in older postmenopausal women: impact of age, body mass index, hysterectomy, hormone therapy use, lifestyle and mood in a cross‐sectional cohort study of 10 418 British women aged 54–65 , 2012, BJOG : an international journal of obstetrics and gynaecology.

[20]  A. Maclennan,et al.  Menopausal hot flushes and night sweats: where are we now? , 2011, Climacteric : the journal of the International Menopause Society.

[21]  H. Teede,et al.  Potential adverse impact of ovariectomy on physical and psychological function of younger women with breast cancer , 2011, Menopause.

[22]  Dawn L Hershman,et al.  Association between prescription co-payment amount and compliance with adjuvant hormonal therapy in women with early-stage breast cancer. , 2011, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[23]  Hui Lin,et al.  Duration of Menopausal Hot Flushes and Associated Risk Factors , 2011, Obstetrics and gynecology.

[24]  Miri Cohen,et al.  Posttraumatic growth in breast cancer survivors: a comparison of volunteers and non‐volunteers , 2011, Psycho-oncology.

[25]  E. Mann,et al.  A cognitive model of menopausal hot flushes and night sweats. , 2010, Journal of psychosomatic research.

[26]  Moon-Soo Lee,et al.  Factors Influencing the Severity of Menopause Symptoms in Korean Post-menopausal Women , 2010, Journal of Korean medical science.

[27]  J. Younus,et al.  Management of hot flashes in women with breast cancer , 2010, Current oncology.

[28]  X. Shu,et al.  Menopausal symptoms among breast cancer patients 6 months after diagnosis: a report from the Shanghai Breast Cancer Survival Study , 2009, Menopause.

[29]  I. Fentiman,et al.  Evaluation of a group cognitive behavioural intervention for women suffering from menopausal symptoms following breast cancer treatment , 2009, Psycho-oncology.

[30]  J. Haviland,et al.  Menopausal hot flushes after breast cancer. , 2009, European journal of cancer care.

[31]  K. Matthews,et al.  Beyond frequency: who is most bothered by vasomotor symptoms? , 2008, Menopause.

[32]  H. Kölbl,et al.  Quality of life and adjuvant tamoxifen treatment in breast cancer patients , 2008 .

[33]  M. Hunter,et al.  The Hot Flush Beliefs Scale: a tool for assessing thoughts and beliefs associated with the experience of menopausal hot flushes and night sweats. , 2008, Maturitas.

[34]  K. Horwitz,et al.  Estrogen insensitivity in a model of estrogen receptor positive breast cancer lymph node metastasis. , 2007, Cancer research.

[35]  F. Holmes,et al.  Comparison of menopausal symptoms during the first year of adjuvant therapy with either exemestane or tamoxifen in early breast cancer: report of a Tamoxifen Exemestane Adjuvant Multicenter trial substudy. , 2007, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[36]  S. Heidrich,et al.  Symptoms, symptom beliefs, and quality of life of older breast cancer survivors: a comparative study. , 2006, Oncology nursing forum.

[37]  N. Johnson,et al.  Side effects of aromatase inhibitors versus tamoxifen: the patients' perspective. , 2006, American journal of surgery.

[38]  T. Marshall,et al.  Menopausal symptoms in women treated for breast cancer: the prevalence and severity of symptoms and their perceived effects on quality of life , 2006, Climacteric : the journal of the International Menopause Society.

[39]  Hui Lin,et al.  The role of anxiety and hormonal changes in menopausal hot flashes , 2005, Menopause.

[40]  I. Fentiman,et al.  Menopausal symptoms in women with breast cancer: Prevalence and treatment preferences , 2004, Psycho-oncology.

[41]  W. Rief,et al.  Causal illness attributions in somatoform disorders: associations with comorbidity and illness behavior. , 2004, Journal of psychosomatic research.

[42]  E. van Limbergen,et al.  Acute effects of tamoxifen and third-generation aromatase inhibitors on menopausal symptoms of breast cancer patients , 2004, Anti-cancer drugs.

[43]  S. Crawford,et al.  Lifestyle and demographic factors in relation to vasomotor symptoms: baseline results from the Study of Women's Health Across the Nation. , 2004, American Journal of Epidemiology.

[44]  C. Agardh,et al.  Menopause-related symptoms: what are the background factors? A prospective population-based cohort study of Swedish women (The Women's Health in Lund Area study). , 2003, American journal of obstetrics and gynecology.

[45]  J. Flaws,et al.  Risk factors for hot flashes in midlife women. , 2003, Journal of women's health.

[46]  P. Remington,et al.  Prevalence and treatment of menopausal symptoms among breast cancer survivors. , 2002, Journal of pain and symptom management.

[47]  E. Lower,et al.  Raloxifene is associated with less side effects than tamoxifen in women with early breast cancer: a questionnaire study from one physician's practice. , 2002, Journal of women's health & gender-based medicine.

[48]  Keith Petrie,et al.  The Revised Illness Perception Questionnaire (IPQ-R) , 2002 .

[49]  B. Weiner,et al.  A meta-analytic review of coping with illness: do causal attributions matter? , 2001, Journal of psychosomatic research.

[50]  J. Kelsey,et al.  Relation of demographic and lifestyle factors to symptoms in a multi-racial/ethnic population of women 40-55 years of age. , 2000, American journal of epidemiology.

[51]  G. Lyman,et al.  Impact of hot flashes on quality of life among postmenopausal women being treated for breast cancer. , 2000, Journal of pain and symptom management.

[52]  P. Novotny,et al.  Tamoxifen-induced hot flashes. , 2000, Clinical breast cancer.

[53]  A. Howell,et al.  Assessment of quality of life in women undergoing hormonal therapy for breast cancer: validation of an endocrine symptom subscale for the FACT‐B , 1999, Breast Cancer Research and Treatment.

[54]  J. Grisso,et al.  Racial differences in menopause information and the experience of hot flashes , 1999, Journal of General Internal Medicine.

[55]  M. Cobleigh,et al.  Ovarian function in premenopausal women treated with adjuvant chemotherapy for breast cancer. , 1996, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[56]  M. Hunter,et al.  A psychological analysis of menopausal hot flushes. , 1995, The British journal of clinical psychology.

[57]  H. Faller,et al.  Causal attribution and adaptation among lung cancer patients. , 1995, Journal of psychosomatic research.

[58]  Howard Leventhal,et al.  Illness cognition: Using common sense to understand treatment adherence and affect cognition interactions , 1992, Cognitive Therapy and Research.

[59]  R. Love,et al.  Symptoms associated with tamoxifen treatment in postmenopausal women. , 1991, Archives of internal medicine.

[60]  G. Zimet,et al.  The Multidimensional Scale of Perceived Social Support , 1988 .

[61]  C. Redmond,et al.  Prolonging tamoxifen therapy for primary breast cancer. Findings from the National Surgical Adjuvant Breast and Bowel Project clinical trial. , 1987, Annals of internal medicine.

[62]  S. Paydaş,et al.  Social support and hopelessness in patients with breast cancer. , 2013, Asian Pacific journal of cancer prevention : APJCP.

[63]  L. Fallowfield,et al.  Recognition and management of treatment-related side effects for breast cancer patients receiving adjuvant endocrine therapy , 2007, Breast Cancer Research and Treatment.

[64]  Connie M Weaver,et al.  The role of calcium in peri- and postmenopausal women: 2006 position statement of the North American Menopause Society. , 2006, Menopause.

[65]  Janet S Carpenter,et al.  Hot flashes and related outcomes in breast cancer survivors and matched comparison women. , 2002, Oncology nursing forum.

[66]  S. Crawford,et al.  Psychosocial, behavioral, and health factors related to menopause symptomatology. , 1997, Women's health.

[67]  M. Hunter.  Predictors of menopausal symptoms: psychosocial aspects. , 1993, Bailliere's clinical endocrinology and metabolism.

[68]  M. Hunter.  3 Predictors of menopausal symptoms: psychosocial aspects , 1993 .

[69]  G. Huston.  The Hospital Anxiety and Depression Scale. , 1987, The Journal of rheumatology.

[70]  J. B. Gregg,et al.  DEPARTMENT OF HEALTH. , 1910, California state journal of medicine.